SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-009939
Filing Date
2022-03-01
Accepted
2022-03-01 08:58:13
Documents
16
Period of Report
2022-02-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea156233-8k_nanomix.htm   iXBRL 8-K 40368
2 FORM OF SENIOR SECURED CONVERTIBLE NOTE, DATED FEBRUARY 25, 2022 ea156233ex4-1_nanomix.htm EX-4.1 322685
3 FORM OF WARRANT, DATED FEBRUARY 25, 2022 ea156233ex4-2_nanomix.htm EX-4.2 176023
4 SECURITIES PURCHASE AGREEMENT, DATED FEBRUARY 25, 2022 ea156233ex10-1_nanomix.htm EX-10.1 338537
5 CONSENT, AMENDMENT AND WAIVER, DATED FEBRUARY 24, 2022 ea156233ex10-2_nanomix.htm EX-10.2 25586
  Complete submission text file 0001213900-22-009939.txt   1276306

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE nnmx-20220228.xsd EX-101.SCH 3033
7 XBRL LABEL FILE nnmx-20220228_lab.xml EX-101.LAB 34476
8 XBRL PRESENTATION FILE nnmx-20220228_pre.xml EX-101.PRE 22595
10 EXTRACTED XBRL INSTANCE DOCUMENT ea156233-8k_nanomix_htm.xml XML 3166
Mailing Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843
Business Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843 (603) 935-9799
NANOMIX Corp (Filer) CIK: 0001473579 (see all company filings)

IRS No.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54586 | Film No.: 22694278
SIC: 2834 Pharmaceutical Preparations